IMM 20.3% 35.5¢ immutep limited

Ann: Operational Update, page-7

  1. 711 Posts.
    lightbulb Created with Sketch. 274
    I’m also encouraged by the recruitment - more than 50 patients - into the tacti-02 lung cancer trial. It’s been less than 6 months since the announcement that an additional 70 patients would be added to the trial

    At this rate the trial will be fully recruited by the end of the year

    I think getting patients on the trial so quickly is a strong signal that MSD - and oncologists - are pretty excited about the potential
    Last edited by megamutts: 07/05/21
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.